EdgarLookup

Keros Therapeutics, Inc.

KROS NASDAQ CIK: 0001664710 Pharmaceutical Preparations
View on SEC.gov →
Overview All Filings Annual Quarterly Insiders

Recent Filings

All 481 filings →
Form Description Date
4/A Mar 27, 2026
SCHEDULE 13G/A Mar 27, 2026
4 Mar 11, 2026
3 Mar 11, 2026
4 Mar 11, 2026
8-K 8-K Mar 9, 2026
8-K 8-K Mar 4, 2026
S-8 S-8 Mar 4, 2026
10-K 10-K Mar 4, 2026
8-K 8-K Mar 4, 2026

Insider Transactions

View all →
Insider Title Type Shares Owns After Date
Pontifax (China) IV L.P. Sale 1,121,045 @ $17.75 Oct 15, 2025
Schneeberger Daniel Sale 743,358 @ $17.75 Oct 15, 2025
Seehra Jasbir CHIEF EXECUTIVE OFFICER Award / Grant 90,500 392,723 Sep 3, 2025
Knowles Julius Award / Grant 5,250 6,441 Jun 4, 2025
GORDON CARL L Award / Grant 5,250 5,250 Jun 4, 2025
Kariv Tomer Award / Grant 5,250 5,250 Jun 4, 2025
Nussbaum Ran Award / Grant 5,250 5,250 Jun 4, 2025
Seth Alpna Award / Grant 5,250 5,250 Jun 4, 2025
GRAY MARY ANN Award / Grant 5,250 5,250 Jun 4, 2025
Farzan Nima Award / Grant 5,250 5,250 Jun 4, 2025